Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2011
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantationKarim E Abou-Nassar, Haesook T Kim, Jeff Blossom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndromeJohn Koreth, Melinda Biernacki, Julie Aldridge, et al.
Genome Research|October 19, 2004
Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi libraryJean-François Rual, Julian Ceron, John Koreth, et al.
American Journal of Hematology|February 20, 2014
White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcomeHaesook T Kim, David Frederick, Philippe Armand, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantationVincent T Ho, Haesook T Kim, Julie Aldridge, et al.
Transplantation and Cellular Therapy|September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center ExperienceKuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.
The Journal of Clinical Investigation|April 15, 2010
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantationKen-ichi Matsuoka, Haesook T Kim, Sean McDonough, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2017
Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell TransplantationDaniel P Prestes, Esther Arbona, Alexandra Nevett-Fernandez, et al.
Pageof 18